3 completed, 2 recruiting, 1 active not recruiting, 1 withdrawn. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 3, Recruiting 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Withdrawn 1 |
Follow High Blood Pressure: new trials by email Literature Review of High Blood Pressure trials Research Report on High Blood Pressure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High - Type 2 Diabetes, High Blood Pressure | Phase 1 / Phase 2 | Withdrawn | ARKAY Therapeutics | 2026-12-10 | 2026-07-16 | |
| Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study Egg White Powder - High Blood Sugar, High Blood Pressure | Phase 1 | Recruiting | University of Alberta | 28 | 2026-02-25 | 2026-10-26 |
| Polypill for Prevention of Cardiomyopathy Polypill, Combined prescription of the individual medications - Type 2 Diabetes, High Blood Pressure | Phase 1 / Phase 2 | Recruiting | University of Texas Southwestern Medical Center | 200 | 2024-03-11 | 2026-08-04 |
| Salt-Sensitivity and Immunity Cell Activation Furosemide 40 mg - High Blood Pressure, Salt; Excess | Phase 1 / Phase 2 | Active not recruiting | Vanderbilt University Medical Center | 20 | 2021-09-01 | 2025-10-21 |
| Healthy Bodies, Healthy Hearts: A Physical Activity Intervention Trial In Person, At Home - Obesity, Cardiovascular Disease | Phase 1 | Completed | University of Pittsburgh | 99 | 2009-06-01 | 2014-05-22 |
| The Effect of Amiloride and Spironolactone in Healthy Persons Amiloride, Spironolactone, Placebo - High Blood Pressure | Phase 1 | Completed | Regional Hospital Holstebro | 30 | 2009-01-01 | 2011-07-08 |
| Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions Nadolol (1 x 80 mg) Tablets (Invamed, Inc), Corgard (1 x 80 mg) Tablets (Bristol Laboratories) - High Blood Pressure, Migraine Headaches | Phase 1 | Completed | Sandoz | 34 | 1994-07-01 | 2017-03-28 |
Hypertension (7) · Obesity (3) · Diabetes Mellitus, Type 2 (2) · Arthritis (1) · Cardiovascular Diseases (1) · Chest Pain (1) · Diabetes Mellitus (1) · Diabetic Cardiomyopathies (1) · Hyperglycemia (1) · Inflammation (1) · Migraine Disorders (1) · Motor Activity (1) · Overweight (1) · Weight Loss (1)
Vascular Diseases (7) · Cardiovascular Diseases (6) · Pathological Conditions, Signs and Symptoms (5) · Nutritional and Metabolic Diseases (4) · Signs and Symptoms (4) · Body Weight (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutrition Disorders (3) · Overnutrition (3) · Endocrine System Diseases (2) · Overweight (2) · Behavior (1) · Body Weight Changes (1) · Brain Diseases (1)
Amiloride (1) · Carboxylesterase (1) · Celecoxib (1) · Furosemide (1) · Losartan (1) · Metformin (1) · Nadolol (1) · Spironolactone (1) · Valine (1) · Valsartan (1) · empagliflozin (1) · finerenone (1)
ARKAY Therapeutics (1) · Regional Hospital Holstebro (1) · Sandoz (1) · University of Alberta (1) · University of Pittsburgh (1) · University of Texas Southwestern Medical Center (1) · Vanderbilt University Medical Center (1)
United States (4) · Canada (1) · Denmark (1)
Ambarish Pandey, MD, MSCS (1) · Annet Kirabo (1) · Erling B Pedersen, Prof (1) · Jianping Wu, PhD (1) · Ravi Kumar, Ph.D. (1) · Terry L. Wolff, D.O. (1)
K23HL085405 (1)